XML 28 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Subsequent Events
3 Months Ended
Mar. 31, 2017
Subsequent Events  
Subsequent Events

 

Note 12.  Subsequent Events

 

In April 2017, the Company paid $10 million for the event based milestone related to the achievement of 100% enrollment in the Phase 3 clinical study of SD-101.